RxDoctor Payments Data

Angela Adams

Family · Blackshear, GANPI 1245580414

Payments from drug & device makers

$686in general payments, 2019–2025

Across 38 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$166
  • Novo Nordisk$104
  • Astellas Pharma US Inc$92
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$68
  • Boston Scientific$61
  • GSK$49
  • plus $146 from 7 others

What the payments were for

  • Food & beverage$686100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$686 in reported general payments places this provider in the 60th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$44,572
Medicare patients
183
Services billed
1,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide24$29,645
MounjaroTirzepatide18$27,083
LinzessLinaclotide26$18,528
EliquisApixaban15$15,639
FarxigaDapagliflozin Propanediol15$14,647
JanuviaSitagliptin Phosphate14$12,333
MyrbetriqMirabegron14$10,691
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,564
Albuterol Sulfate HfaAlbuterol Sulfate117$3,269
Cefdinir95$1,556
Gabapentin104$1,546
Acetaminophen-CodeineAcetaminophen With Codeine49$1,140
Omeprazole88$1,104
Atorvastatin Calcium151$999
Levothyroxine Sodium138$995

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$18$18,52826 claims
PfizerEliquis$166$15,63915 claims
Astellas Pharma US IncMyrbetriq$92$10,69114 claims
GSKTrelegy Ellipta$49$10,56417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,258 family providers in Georgia.

Other family in Blackshear

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →